Search filters

List of works by Larry D Anderson

A peptide prime-DNA boost immunization protocol provides significant benefits as a new generation Aβ42 DNA vaccine for Alzheimer disease.

scientific article

Adoptive T-cell therapy for B-cell malignancies

scientific article published on October 2009

Bone marrow transplant conditioning intensified with liposomal clodronate to eliminate residual host antigen presenting cells fails to ameliorate GVHD and increases PERI-BMT mortality

scientific article published in March 2001

DNA immunization against amyloid beta 42 has high potential as safe therapy for Alzheimer's disease as it diminishes antigen-specific Th1 and Th17 cell proliferation

scientific article published on 6 April 2011

Enhancement of graft-versus-tumor activity and graft-versus-host disease by pretransplant immunization of allogeneic bone marrow donors with a recipient-derived tumor cell vaccine

scientific article published on 01 April 1999

Esophago-respiratory fistula

scientific article published in August 2003

Ganciclovir chemoablation of herpes thymidine kinase suicide gene-modified tumors produces tumor necrosis and induces systemic immune responses

scientific article published on September 1998

HER-2/neu peptide specificity in the recognition of HLA-A2 by natural killer cells

scientific article published on 01 October 1999

Ibrutinib Use Complicated by Progressive Multifocal Leukoencephalopathy

scientific article published on 25 July 2018

Ibrutinib alone or with dexamethasone for relapsed or relapsed and refractory multiple myeloma: phase 2 trial results.

scientific article published on 13 February 2018

Identification of MAGE-C1 (CT-7) epitopes for T-cell therapy of multiple myeloma

scientific article published on 03 April 2011

Immunization of allogeneic bone marrow transplant recipients with tumor cell vaccines enhances graft-versus-tumor activity without exacerbating graft-versus-host disease

scientific article published on 01 April 2000

Nonmyeloablative allogeneic hematopoietic cell transplantation for relapsed or refractory Waldenstrom macroglobulinemia: Evidence for a graft-versus-lymphoma effect.

scientific article

Phase 1 trial of ibrutinib and carfilzomib combination therapy for relapsed or relapsed and refractory multiple myeloma

scientific article published on 4 April 2018

Pomalidomide, bortezomib, and dexamethasone for multiple myeloma previously treated with lenalidomide (OPTIMISMM): outcomes by prior treatment at first relapse

scientific article published on 07 September 2020

Pretransplant tumor antigen-specific immunization of allogeneic bone marrow transplant donors enhances graft-versus-tumor activity without exacerbation of graft-versus-host disease

scientific article published on 01 October 2000

Successful treatment of relapsed and refractory extramedullary acute promyelocytic leukemia with tamibarotene

scientific article published on 11 April 2011

Targeting B-cell maturation antigen with GSK2857916 antibody-drug conjugate in relapsed or refractory multiple myeloma (BMA117159): a dose escalation and expansion phase 1 trial

scientific article published on 12 November 2018

Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma

Understanding the Relationship Between Care Volume and Clinical Outcomes in Multiple Myeloma.

scientific article published on 17 January 2017